ResMed's Sales and Profits Rise
ResMed (NYSE: RMD), a medical device marker focused on continuous positive airway pressure (CPAP) machines and accessories, reported its fiscal first-quarter results on Thursday, Oct. 26. The company's top and bottom lines once again moved in the right direction and compared favorably to what market watchers had predicted. Investors applauded the company's success.
Image source: Getty Images.
Metric
Source: Fool.com
Resmed Inc. Stock
€196.70
0.260%
Resmed Inc. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
As a result the target price of 258 € shows a positive potential of 31.16% compared to the current price of 196.7 € for Resmed Inc..


